Revolutionizing RNA therapeutics - Avidity Biosciences

Sarah Boyce from Avidity Biosciences and Piratip Pratumsuwan from RTW Investments explore the strategic decisions and innovations that have driven Avidity's success. They cover her approach to overcoming the challenges of scaling a biotech company, the impact of Avidity’s groundbreaking work on treating rare genetic disorders, and Sarah’s vision for the future of RNA-based therapies.

PODCAST TEAM

Producer: Devon Leaver

Technical Director: Joseph Sebring

Editor: Dominique Guerra

Featuring: Sarah Boyce, President and CEO of